Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C28H26FN3 |
| Molecular Weight | 423.5245 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC=C(C=C1)C2=C(C(=CN2)C3=CCN(CCC4=CC=CC=C4)CC3)C5=CC=NC=C5
InChI
InChIKey=XLEONXLSQBBRAN-UHFFFAOYSA-N
InChI=1S/C28H26FN3/c29-25-8-6-24(7-9-25)28-27(23-10-15-30-16-11-23)26(20-31-28)22-13-18-32(19-14-22)17-12-21-4-2-1-3-5-21/h1-11,13,15-16,20,31H,12,14,17-19H2
| Molecular Formula | C28H26FN3 |
| Molecular Weight | 423.5245 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Novel p38 mitogen-activated protein kinase inhibitor R-130823 protects cartilage by down-regulating matrix metalloproteinase-1,-13 and prostaglandin E2 production in human chondrocytes. | 2006-02 |
|
| Novel p38 MAP kinase inhibitor R-130823 suppresses IL-6, IL-8 and MMP-13 production in spheroid culture of human synovial sarcoma cell line SW 982. | 2005-10-15 |
|
| R-130823, a novel inhibitor of p38 MAPK, ameliorates hyperalgesia and swelling in arthritis models. | 2005-01-04 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:31:14 GMT 2025
by
admin
on
Mon Mar 31 22:31:14 GMT 2025
|
| Record UNII |
L2387U4N8Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9910199
Created by
admin on Mon Mar 31 22:31:14 GMT 2025 , Edited by admin on Mon Mar 31 22:31:14 GMT 2025
|
PRIMARY | |||
|
L2387U4N8Y
Created by
admin on Mon Mar 31 22:31:14 GMT 2025 , Edited by admin on Mon Mar 31 22:31:14 GMT 2025
|
PRIMARY | |||
|
321344-32-5
Created by
admin on Mon Mar 31 22:31:14 GMT 2025 , Edited by admin on Mon Mar 31 22:31:14 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |